Department of Gastroenterology, St. Vincent's Hospital, Melbourne, Victoria, Australia.
Inflamm Bowel Dis. 2010 Sep;16(9):1550-6. doi: 10.1002/ibd.21209.
To date, there have been no population-based epidemiological studies published from Australia concerning the incidence of inflammatory bowel disease (IBD). Our hypothesis was that the incidence of IBD in Australia is at least as high as other industrialized countries, given similar genetic and environmental risk factors.
A prospective, population-based IBD incidence study was conducted between April 2007 and March 2008 in Greater Geelong, Victoria, Australia. According to 2006 Australian Census data, this comprises an at-risk population of 259,015. Cases were ascertained from multiple overlapping sources. All local general practitioners, gastroenterologists, surgeons, and pediatricians were contacted every 2 months to identify new IBD cases. The Royal Children's Hospital in Melbourne, local endoscopy and pathology centers were also searched to ensure completeness of case capture. Standard IBD case definitions were used with clinical, endoscopic, and histological criteria.
In all, 76 new cases of IBD were identified during the 1-year period. There were 45 cases of Crohn's disease, 29 of ulcerative colitis, and 2 of indeterminate colitis. The crude annual incidence rates for IBD overall, Crohn's disease, ulcerative colitis, and indeterminate colitis were 29.3 per 100,000 (95% confidence interval [CI] 23.5-36.7 per 100,000), 17.4 per 100,000, 11.2 per 100,000, and 0.8 per 100,000, respectively. When directly age-standardized to the World Health Organization standard population the overall IBD incidence rate was 29.6 per 100,000.
This is the first prospective, Australian population-based IBD incidence study. The incidence rates are among the highest reported in the literature of IBD.
迄今为止,澳大利亚尚未有基于人群的炎症性肠病(IBD)发病率研究发表。我们的假设是,鉴于相似的遗传和环境风险因素,澳大利亚的 IBD 发病率至少与其他工业化国家一样高。
我们于 2007 年 4 月至 2008 年 3 月在澳大利亚维多利亚州的大吉隆进行了一项前瞻性、基于人群的 IBD 发病率研究。根据 2006 年澳大利亚人口普查数据,该地区有 259015 名高危人群。通过多个重叠的来源确定病例。每两个月联系当地的全科医生、胃肠病学家、外科医生和儿科医生,以确定新的 IBD 病例。还在墨尔本的皇家儿童医院、当地的内镜和病理中心进行了搜索,以确保病例捕获的完整性。使用临床、内镜和组织学标准采用标准的 IBD 病例定义。
在这 1 年期间,共发现 76 例新的 IBD 病例。其中 45 例为克罗恩病,29 例为溃疡性结肠炎,2 例为不确定结肠炎。IBD 总体、克罗恩病、溃疡性结肠炎和不确定结肠炎的粗年发病率分别为 29.3/100000(95%置信区间 [CI] 23.5-36.7/100000)、17.4/100000、11.2/100000 和 0.8/100000。当直接按世界卫生组织标准人群年龄标准化时,IBD 的总体发病率为 29.6/100000。
这是第一项前瞻性、澳大利亚人群 IBD 发病率研究。发病率属于文献中报道的最高之列。